Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Pharma-Bio Serv (PBSV) over the last 17 years, with Q4 2025 value amounting to $279316.0.

  • Pharma-Bio Serv's Free Cash Flow rose 45540.91% to $279316.0 in Q4 2025 from the same period last year, while for Oct 2025 it was -$221530.0, marking a year-over-year increase of 6950.49%. This contributed to the annual value of -$221530.0 for FY2025, which is 6950.49% up from last year.
  • Pharma-Bio Serv's Free Cash Flow amounted to $279316.0 in Q4 2025, which was up 45540.91% from $234488.0 recorded in Q3 2025.
  • Over the past 5 years, Pharma-Bio Serv's Free Cash Flow peaked at $1.1 million during Q3 2022, and registered a low of -$1.2 million during Q2 2021.
  • Over the past 5 years, Pharma-Bio Serv's median Free Cash Flow value was $241221.0 (recorded in 2022), while the average stood at $114878.2.
  • As far as peak fluctuations go, Pharma-Bio Serv's Free Cash Flow crashed by 17932.44% in 2024, and later surged by 45540.91% in 2025.
  • Over the past 5 years, Pharma-Bio Serv's Free Cash Flow (Quarter) stood at $961231.0 in 2021, then plummeted by 74.2% to $247954.0 in 2022, then rose by 25.03% to $310016.0 in 2023, then crashed by 125.35% to -$78590.0 in 2024, then surged by 455.41% to $279316.0 in 2025.
  • Its Free Cash Flow was $279316.0 in Q4 2025, compared to $234488.0 in Q3 2025 and -$305848.0 in Q2 2025.